Phase I Study of PF-00477736 With Gemcitabine In Patients With Advanced Solid Malignancies.
Phase of Trial: Phase I
Latest Information Update: 02 Apr 2012
At a glance
- Drugs Gemcitabine; PF 477736
- Indications Solid tumours
- Focus Adverse reactions; Biomarker
- 19 Jul 2011 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 12 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Apr 2011 Planned End Date changed from 1 Feb 2011 to 1 Apr 2011.